A detailed history of West End Advisors, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, West End Advisors, LLC holds 34 shares of JNJ stock, worth $5,205. This represents 0.0% of its overall portfolio holdings.

Number of Shares
34
Previous 46 26.09%
Holding current value
$5,205
Previous $6,000 16.67%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

SELL
$145.48 - $167.38 $1,745 - $2,008
-12 Reduced 26.09%
34 $5,000
Q2 2024

Jul 29, 2024

SELL
$144.38 - $157.78 $30 Million - $32.8 Million
-207,673 Reduced 99.98%
46 $6,000
Q1 2024

May 07, 2024

BUY
$155.22 - $162.74 $24,369 - $25,550
157 Added 0.08%
207,719 $32.9 Million
Q4 2023

Jan 18, 2024

SELL
$145.6 - $158.88 $983,236 - $1.07 Million
-6,753 Reduced 3.15%
207,562 $32.5 Million
Q3 2023

Oct 19, 2023

BUY
$155.75 - $174.48 $762,396 - $854,079
4,895 Added 2.34%
214,315 $33.4 Million
Q2 2023

Jul 21, 2023

SELL
$154.35 - $166.11 $612,923 - $659,622
-3,971 Reduced 1.86%
209,420 $34.7 Million
Q1 2023

Apr 28, 2023

BUY
$151.05 - $180.26 $2.82 Million - $3.36 Million
18,651 Added 9.58%
213,391 $33.1 Million
Q4 2022

Jan 31, 2023

SELL
$160.2 - $179.79 $1.78 Million - $1.99 Million
-11,086 Reduced 5.39%
194,740 $34.4 Million
Q3 2022

Oct 27, 2022

SELL
$161.33 - $179.52 $157,942 - $175,750
-979 Reduced 0.47%
205,826 $33.6 Million
Q2 2022

Jul 28, 2022

SELL
$168.19 - $186.01 $7.79 Million - $8.62 Million
-46,318 Reduced 18.3%
206,805 $36.7 Billion
Q1 2022

Apr 26, 2022

SELL
$158.14 - $179.59 $2.97 Million - $3.37 Million
-18,790 Reduced 6.91%
253,123 $44.9 Billion
Q4 2021

Jan 14, 2022

BUY
$155.93 - $173.01 $590,039 - $654,669
3,784 Added 1.41%
271,913 $46.5 Billion
Q3 2021

Oct 26, 2021

BUY
$161.5 - $179.47 $142,120 - $157,933
880 Added 0.33%
268,129 $43.3 Billion
Q2 2021

Jul 15, 2021

BUY
$159.48 - $171.07 $3.43 Million - $3.68 Million
21,522 Added 8.76%
267,249 $44 Billion
Q1 2021

Apr 27, 2021

BUY
$153.07 - $170.48 $2.01 Million - $2.24 Million
13,132 Added 5.65%
245,727 $40.4 Billion
Q4 2020

Jan 28, 2021

SELL
$137.11 - $157.38 $876,407 - $1.01 Million
-6,392 Reduced 2.67%
232,595 $36.6 Billion
Q3 2020

Oct 22, 2020

BUY
$140.38 - $153.83 $792,164 - $868,062
5,643 Added 2.42%
238,987 $35.6 Billion
Q2 2020

Jul 22, 2020

BUY
$128.81 - $155.51 $1.81 Million - $2.19 Million
14,074 Added 6.42%
233,344 $32.8 Billion
Q1 2020

May 05, 2020

SELL
$111.14 - $153.99 $3.17 Million - $4.4 Million
-28,564 Reduced 11.53%
219,270 $28.8 Billion
Q4 2019

Feb 12, 2020

BUY
$127.5 - $146.44 $3.22 Million - $3.7 Million
25,235 Added 11.34%
247,834 $36.2 Billion
Q3 2019

Nov 07, 2019

SELL
$126.95 - $142.14 $2.24 Million - $2.51 Million
-17,673 Reduced 7.36%
222,599 $28.8 Billion
Q2 2019

Jul 23, 2019

BUY
$131.15 - $144.24 $31.5 Million - $34.7 Million
240,272 New
240,272 $33.5 Billion

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $400B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track West End Advisors, LLC Portfolio

Follow West End Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of West End Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on West End Advisors, LLC with notifications on news.